Corporate

Subscribe to Corporate via RSS

By King & Wood Mallesons’ Labor & Employment Group

On December 28, 2012, the Decision regarding the Modification of Employment Contract Law (the “Decision”) was passed by the 30th Session of the Standing Committee of the 11th National People’s Congress, which is to take effect on July 1, 2013. This Decision amends the section in the Employment Contract Law relating to dispatched personnel, which provides rules on the qualifications of the dispatch service provider, the administrative license requirements for the dispatch service provider, the concept of “equal pay for equal work” as it applies to dispatched personnel and the company’s direct hire counterparts for the same job position in the same location, and the job descriptions of the positions for which companies are permitted to hire dispatched personnel.
Continue Reading Executive Summary of the Modification of the Employment Contract Law

作者：金杜律师事务所劳动法组

2012年12月28日，十一届全国人大常委会第三十次会议表决通过了《关于修改劳动合同法的决定》(“决定”)，该“决定”将于2013年7月1日起正式实施。此次修订是针对于《劳动合同法》中有关于劳务派遣的相关规定，对于劳务派遣单位的经营资质、经营劳务派遣业务的行政许可、被派遣员工与用工单位员工的“同工同酬”、可以适用劳务派遣的“三性”岗位等内容予以细化与明确。
Continue Reading 《劳动合同法》修订概要

《跨国战略——中国企业海外投资法律与实务》是金杜律师事务所资深合伙人徐萍律师关于中国企业境外投资并购的新作。

本书从专门从事跨境并购的律师视角，以作者亲身参与的大量跨境并购的实战经验为基础，对境外投资各种形式及环节进行概括性的介绍。境外投资由于涉及的地域、行业和交易形式各异，所涉及问题千差万别，难以一概而论。本书旨在阐述和提示境外投资并购一些常见的法律和商务风险，并提出应对之策。本书内容丰富，详细介绍了中国企业“走出去”的方方面面可能遇到的问题，具有很强的实用性和针对性，是作者跨境并购法律服务经验和智慧的结晶，也同时体现了金杜处理并购领域复杂交易的综合实力。
Continue Reading 新书推荐 – 《跨国战略——中国企业境外投资法律与实务》

作者：尤杨、蔺楷毅、赵之涵 金杜律师事务所争议解决组

you_yang近期，安信信托投资股份有限公司（下称“安信信托”）与昆山纯高投资开发有限公司（下称“昆山纯高”）金融借款合同纠纷案（下称“本案”）引起了业内的广泛关注。在本案中，双方当事人就信托合同的效力、收益权的性质等问题进行了深入的探讨，相信本案的审理结果势必会为各信托公司在未来设立信托计划时提供警示和参考。
Continue Reading 信托实务专题之(五)：公证债权文书的“牢笼”—— 结合安信信托与昆山纯高案浅析公证债权文书的可诉性

By Kalley Chen  King & Wood Mallesons’ Securities Group

To address China’s aging population issue as well as its need to improve access to healthcare in rural areas, healthcare reform has become a priority for the Chinese government.

A key mechanism to improve access is through the promotion of private healthcare. While current exit restrictions exist in relation to private medical institutions, recent policy developments which have liberalized investment in the healthcare sector demonstrate China’s progress toward improving healthcare. It is likely that these policies may stimulate greater PE investment opportunities, in particular within the private healthcare sector.
Continue Reading The promotion of private healthcare services- A Challenge or an opportunity?

作者：陈慧  金杜律师事务所证券组

为了解决中国人口老龄化问题，同时改善农村地区医疗水平，医疗改革已经成为中国政府优先关注的问题。

发展私营医疗产业是提升医疗水平的一个主要机制。虽然私营医疗机构目前存在退出限制，但是政府近期颁布的一系列新政，使得医疗健康领域的投资更加开放，显示了中国在提升医疗服务水平方面的进展。这些政策很可能促进更多的私募投资机会，特别是私营医疗服务领域。
Continue Reading 大力发展私营医疗服务：挑战还是机会？

By King & Wood Mallesons’ Healthcare Group

Some recent news releases show that the PRC Ministry of Health has proposed to revise (the “Proposed Revision”) the current Measures for Inspection of Medical Advertisement (promulgated on 13 March 2007 and effective as of 1 May 2007) (the “2007 Measures”).

Among all other changes in the Proposed Revision, one hot-button issue is that, except for general information and name of the medicine, any other specific information (e.g. usage) regarding all medicine, including OTC medicines, is no longer allowed in public-oriented media, and only allowed in professional media. Compared with the 2007 Measures, which allowed OTC medicine advertisement to be used in public media, but subject to inspection by the SFDA. However, the Proposed Revision might ban this practice.
Continue Reading Proposed Change on Medical Advertisement Related Regulation Might Cease All Advertisement for Otc Medicines in Public Media

作者：金杜律师事务所医疗法律事务组 

近期发布的消息显示，中国卫生部已计划对现行有效的于2007年3月13日发布并于2007年5月1日生效的《药品广告审查办法》(“2007年办法”)进行修订并透露了部分修订意见(“修订意见”)。

在修订意见的所有修改中，一个热点在于除药品名称和一般信息外，禁止就所有药品包括非处方药品(OTC药品)的任何特定信息(如，使用方法)进行以公众为对象的广告宣传，而仅能在专业媒体上进行广告宣传。与2007年办法相比较，非处方药品曾可以公众媒体进行广告宣传，但是需要受限于国家食品药品监督管理局的审查。然而，在修订意见中可能完全禁止该类广告。
Continue Reading 所有对非处方药品的大众媒体广告宣传将可能因药品广告有关法规的修订而终止

By Mark Schaub and Chen Bing King & Wood Mallesons’ Foreign Direct Investment (FDI) Group

It would be safe to say that when Hong Kong rejoined China as a Special Administrative Region in 1997 there was little thought, if any, paid to milk powder and its effect on relations with the mainland. However, recent restrictions introduced in Hong Kong on the sale and distribution of milk powder produced by mainland suppliers has become a major, and indeed emotional, issue. As the 12th Chinese People’s Political Consultative Conference National Committee (“CPPCC”) and 12th National People’s Congress (“NPC”) (the highest authority of the PRC) commenced on March 5, 2013, baby milk grabbed the attention of representatives in both forums.
Continue Reading PRC Food Safety Law: Food for Thought

By WACHTELL, LIPTON, ROSEN & KATZ：Adam O. Emmerich Robin Panovka David A. Katz；King & Wood Mallesons：Wang Kaiding  Jing Gang  Wang Lianghua

More than 40% of global M&A in 2012 involved acquirors and targets in different countries, including $170 billion of acquisitions in the U.S. by non-U.S. acquirors. Given the continuing accumulation of U.S. Dollars in emerging economies, many expect the trend to continue as Dollars are re-invested in the U.S. Natural resources will continue to be an important part of this story, including in the U.S., where substantial non-U.S. investment has been an important trend, as well as in resource-rich developed nations such as Canada and Australia, where non-domestic investment has lately been highly controversial.
Continue Reading Cross-Border M&A – Checklist for Successful Acquisitions in the U.S.